INOZYME PHARMA, INC. Other Accrued Liabilities, Current
INOZYME PHARMA, INC. had Other Accrued Liabilities, Current of $731.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-10.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2025-03-10
- 2024-12-31: Other Accrued Liabilities, Current $731.00K.
- 2023-12-31: Other Accrued Liabilities, Current $883.00K.
- 2023-06-30: Other Accrued Liabilities, Current $490.00K.
- 2023-03-31: Other Accrued Liabilities, Current $559.00K.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2024-12-31 | $731.00K 10-K · filed 2025-03-10 | |
| 2023-12-31 | $883.00K 10-K · filed 2025-03-10 | |
| 2023-06-30 | $490.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $559.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $485.00K 10-K · filed 2024-03-12 | $744.00K 10-K · filed 2023-03-22 |
| 2022-09-30 | $512.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $461.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $824.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $336.00K 10-K · filed 2023-03-22 | |
| 2021-09-30 | $397.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $725.00K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $651.00K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $878.00K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $785.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $785.00K 10-Q · filed 2020-09-03 | |
| 2019-12-31 | $120.00K 10-K · filed 2021-03-25 |